WuXi Biologics (Cayman) Inc (WXXWY)
3.24
+0.05
(+1.57%)
USD |
OTCM |
Apr 22, 16:00
WuXi Biologics Shareholders Equity (Quarterly): 5.690B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.690B |
June 30, 2023 | 5.203B |
June 30, 2023 | 5.203B |
December 31, 2022 | 5.080B |
June 30, 2022 | 5.142B |
June 30, 2022 | 5.142B |
December 31, 2021 | 5.064B |
June 30, 2021 | 5.138B |
June 30, 2021 | 5.138B |
December 31, 2020 | 3.148B |
June 30, 2020 | 1.923B |
Date | Value |
---|---|
June 30, 2020 | 1.923B |
December 31, 2019 | 1.827B |
June 30, 2019 | 1.240B |
June 30, 2019 | 1.240B |
December 31, 2018 | 1.162B |
June 30, 2018 | 1.134B |
June 30, 2018 | 1.134B |
December 31, 2017 | 616.41M |
June 30, 2017 | 564.24M |
June 30, 2017 | 564.24M |
December 31, 2016 | 38.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.240B
Minimum
Jun 2019
5.690B
Maximum
Dec 2023
3.873B
Average
5.080B
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Wuxi AppTec Co Ltd | 7.776B |
Zai Lab Ltd | 796.12M |
I-MAB | 337.31M |
Gracell Biotechnologies Inc (DELISTED) | 222.18M |
Sinovac Biotech Ltd | 8.665B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.981B |
Total Liabilities (Quarterly) | 1.772B |
Debt to Equity Ratio | 0.0532 |
Current Ratio | 2.776 |
Net Debt Paydown Yield | 0.27% |